Airborne Bioagent Detection Using Polarized Light Scattering
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current airborne virus detection techniques are slow and inefficient in capturing small biological agents like SARS-CoV-2, which are difficult to capture with traditional impactors and require extensive sampling and analysis time, and existing methods struggle to detect particles smaller than 2.5 micrometers.
Innovation Solution
A method and system utilizing monochromatic polarized light beams to detect biological agents in real-time by emitting light at specific wavelengths corresponding to absorption maxima of biological molecules, analyzing scattered light with photodetectors to identify and quantify particles based on scattering angles and intensity peaks, enabling rapid detection of particles down to 2.5 micrometers or smaller.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional impactors and precipitators are used to capture airborne particles, then larger particles such as bacteria, fungi or yeasts can be captured, but smaller viruses such as SARS-CoV-2 (120 nm) cannot be effectively captured because they flow with the air
Solution Approach 1:
The patent replaces mechanical impactors with an optical detection system using light scattering. Instead of physically capturing particles on filters or surfaces, the system uses a laser beam to illuminate the air sample and detects scattered light patterns. This substitution allows detection of viruses as small as 120 nm without relying on mechanical capture mechanisms that are size-dependent.
Solution Approach 2:
The patent changes the detection parameter from physical capture to optical scattering characteristics. By measuring the intensity and angular distribution of scattered light, the system can identify particles based on their optical properties rather than their physical size alone. This parameter change enables detection of sub-2.5 micrometer particles that would pass through traditional filters.
2Measurement precision
If extensive sampling is performed to increase the amount of particles collected, then detection sensitivity improves, but the sampling time increases to at least half an hour
Solution Approach 1:
The patent implements continuous real-time detection by maintaining a constant laser beam through the air sample and continuously monitoring scattered light. This eliminates the need for discrete sampling intervals and allows immediate detection as particles pass through the detection zone, reducing sampling time from half an hour to near-real-time operation.
Solution Approach 2:
By replacing mechanical sampling and concentration processes with optical detection, the system achieves high detection sensitivity without requiring extensive sampling time. The light scattering method provides immediate signal generation when particles are present, eliminating the time-consuming steps of filter collection and laboratory analysis.
3Measurement precision
If particles are collected on gelatin filters or in liquid suspension for subsequent analysis, then pathogenic agents can be identified, but the total analysis time requires at least another hour of processing
Solution Approach 1:
The patent replaces wet laboratory analysis methods with optical detection. Instead of collecting particles on filters and performing culture or molecular analysis in the lab, the system uses laser light scattering to identify and characterize particles in real-time. This substitution eliminates the one-hour processing step while maintaining detection accuracy through characteristic scattering patterns of different pathogens.
Solution Approach 2:
The patent creates an optical signature or pattern copy of the particle's physical and optical characteristics through light scattering. This optical copy contains sufficient information to identify the pathogen type without requiring physical isolation or biochemical analysis, dramatically reducing analysis time while preserving identification accuracy.
4Measurement precision
If the wavelength of light is set to correspond to absorption maximum of biological molecules (240-280 nm), then detection specificity for biological agents improves, but the system becomes more specialized for specific wavelength ranges
Solution Approach 1:
The patent optimizes the light wavelength parameter to match the absorption maximum of biological molecules (240-280 nm range). This parameter setting enhances the scattering signal from biological particles by using wavelengths that are strongly absorbed or interacted with by biological materials, thereby improving detection specificity for viruses and bacteria while minimizing background signals from non-biological particles.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables real-time detection of airborne biological agents, particularly viruses such as SARS-CoV-2, by identifying and quantifying their presence, concentration, and size through enhanced scattering analysis, improving detection efficiency and reducing analysis time.
Implementation Method 1
emit, towards a test zone comprising an air sample, a monochromatic polarized light beam whose wavelength corresponds essentially to an absorption maximum of a biological molecule of interest
Implementation Method 2
The monochromatic polarized light beam passes through the air sample present in the test area and, after Mie scattering, is received by photodetectors located in positions corresponding to the different possible scattering angles
Implementation Method 3
Receive, in different positions corresponding to different scattering angles, the scattered light beam after passing through the air sample
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The invention describes a method for detecting biological agents suspended in the air in real time, comprising: emitting, towards an air sample, a beam of monochromatic polarized light whose wavelength corresponds to an absorption maximum of a biological molecule; receiving, at different scattering angles, the scattered light beam after passing through the sample; determining that there are particles in the sample that contain the biological molecules of interest if the intensity of the scattered light has a substantially higher peak than the rest of the scattered light; estimating the amount of said biological molecules according to the amplitude of said peak; and estimating the size of the particles containing the biological molecules as a function of the scattering angle where said peak was detected. The invention also describes a system for carrying out said procedure.